Skip to main content
Fig. 2 | Genome Medicine

Fig. 2

From: Burden of tumor mutations, neoepitopes, and other variants are weak predictors of cancer immunotherapy response and overall survival

Fig. 2

Per-patient distribution of overall tumor variant burden and its components. The number of total tumor variants per patient is shown along the y-axis, with the numbers of retained introns (RI), tumor-specific exon-exon junctions (Jx), insertions/deletions (Indel), and single nucleotide variants (SNV) shown in green, blue, red, and purple, respectively. The data for each individual patient is displayed as stacked bars along the x-axis, sorted from left to right by the number of single nucleotide variants (from highest to lowest)

Back to article page